Home/ Stocks/ KURA

Kura Oncology, Inc.

KURA XNAS

$9.57 +0.29 (+3.12%) ▲ 15-min delayed

Open

$9.37

High

$9.60

Low

$9.34

Volume

749.3K

Market Cap

$823.83M

About Kura Oncology, Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 260 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$18.27M	$-73,333,000	$-0.83
FY 2025	$67.48M	$-278,666,000	$-3.18
Q3 2025	$20.75M	$-74,116,000	$-0.85
Q2 2025	$15.29M	$-66,122,000	$-0.75

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for KURA yet. Check out our latest market news or earnings calendar.

Get KURA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Kura Oncology, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.